Under a new federal rule, health insurers and employers that offer health plans must provide online calculators for patients to get detailed estimates of what they will owe for a range of services and drugs.
Employers are tapping into dollars provided through programs they have previously criticized: patient financial assistance initiatives set up by drugmakers.
Ozempic’s peppy ads suggest that people who use it might lose weight, but also include a disclaimer: that it “is not a weight loss drug.” Now — as Wegovy — it is.
Facing a host of challenges, Aduhelm’s makers are running an educational campaign directed at consumers who are worried about whether their forgetfulness is a sign of disease.
Hospital-level care at home is poised to grow after more than a decade, boosted both by hospitals eager to ease overcrowding and growing interest by insurers who want to slow health care spending.
Starting at the end of last year — and continuing into the spring — a growing number of insurers are quietly ending fee waivers for COVID treatment on some or all policies.